EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
By N. Mottet, J. Bellmunt, Michel Bolla, E. Briers, M. Cumberbatch, M. De Santis, N. Fossati, T. Gross, A. Henry, Steven Joniau and 12 more. European Urology, 2017
2,938 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/80241105a198d43dc5e984312ec9d41f27af3e99
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
- Ewout W. Steyerberg
- B. Van calster
- Andrew J. Vickers
- Michel Bolla
- N. Mottet
- Prashanth Rawla
- J. Bellmunt
- Steven Joniau
In Surgery
Citations in the corpus
- Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. (2019, methodology): “TRUSGB was performed according to international guidelines [17].”
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. (2017, background): “The Guidelines on screening, diagnosis, and treatment of clinically localised and locally advanced PCa were published in a separate paper [2].”
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, background): “The most recent summary of the European Association of Urology (EAU)-European Society for Radiotherapy and Oncology (ESTRO)-International Society of Geriatric Oncology (SIOG) guidelines on prostate cancer (PCa) was published in 2017 [1].”
- Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators (2018, background): “Detecting high-grade prostate cancer is important, because early detection of these potentially lethal cancers can lead to curative treatment [21].”
- Epidemiology of Prostate Cancer (2019, background): “Incidence rates in the USA, Australia, and Canada have seen an increase between the 1980s and 1990s but now decreasing because of rapid dissemination of PSA testing [22, 23], while rates in European countries continue to slightly increase because of increased understanding of PSA screening and gradu”